Last update: Sept. 19, 2016

コンドロイチン硫酸エステルナトリウム

Very Low Risk for breastfeeding


Compatible.
Not risky for breastfeeding or infant.

Copolymer which is found in nature that is obtained from cartilage of various terrestrial or marine animals and used in the treatment of osteoarthritis.
It is a mucopolysaccharide which is formed by polymers of glycosaminoglycan (GAG) and devoid of toxicity.

It is presented in the human body and breast milk, with the highest concentration in the milk of mothers of preterm babies. (Coppa 2012).
Half concentration of GAG in the milk is contained as chondroitin sulfate with anti-infectious properties; among others, it protects the gastrointestinal tract of infants against infections (Maccari 2016).
Its concentration is not affected by Holder pasteurization method of breast milk.
Changes on the composition of chondroitin sulfate in the milk have been detected in cases of breast cancer.

Because a high molecular weight the passage of significant amounts into milk is highly unlikely.
Its low oral bioavailability hinders the passage from ingested milk to the infant plasma.

Alternatives

We do not have alternatives for コンドロイチン硫酸エステルナトリウム since it is relatively safe.

Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Other names

コンドロイチン硫酸エステルナトリウム is Chondroitin Sulfate Sodium in Japanese.

Is written in other languages:

Group

コンドロイチン硫酸エステルナトリウム belongs to this group or family:

Tradenames

Main tradenames from several countries containing コンドロイチン硫酸エステルナトリウム in its composition:

Pharmacokinetics

Variable Value Unit
Bioavailability 15 %
Molecular weight 50.000 daltons
Protein Binding 85 %
VD 0,3 l/Kg
Tmax 4 hours
T1/2 5 - 15 hours

References

  1. Coppa GV, Facinelli B, Magi G, Marini E, Zampini L, Mantovani V, Galeazzi T, Padella L, Marchesiello RL, Santoro L, Coscia A, Peila C, Volpi N, Gabrielli O. Human milk glycosaminoglycans inhibit in vitro the adhesion of Escherichia coli and Salmonella fyris to human intestinal cells. Pediatr Res. 2016 Abstract
  2. Maccari F, Mantovani V, Gabrielli O, Carlucci A, Zampini L, Galeazzi T, Galeotti F, Coppa GV, Volpi N. Metabolic fate of milk glycosaminoglycans in breastfed and formula fed newborns. Glycoconj J. 2016 Abstract
  3. AEMPS. Condroitín. Ficha técnica. 2016 Full text (in our servers)
  4. Coscia A, Peila C, Bertino E, Coppa GV, Moro GE, Gabrielli O, Zampini L, Galeazzi T, Maccari F, Volpi N. Effect of holder pasteurisation on human milk glycosaminoglycans. J Pediatr Gastroenterol Nutr. 2015 Abstract
  5. Volpi N, Gabrielli O, Carlucci A, Zampini L, Santoro L, Padella L, Marchesello RL, Maccari F, Coppa GV. Human milk glycosaminoglycans in feces of breastfed newborns: preliminary structural elucidation and possible biological role. Breastfeed Med. 2014 Abstract
  6. Newburg DS. Glycobiology of human milk. Biochemistry (Mosc). 2013 Abstract
  7. AESAN. Informe del Comité Científico de la Agencia Española de Seguridad Alimentaria y Nutrición (AESAN) sobre condiciones de uso de determinadas sustancias distintas de vitaminas, minerales y plantas para ser empleadas en complementos alimenticios - 1. Revista del comité científico nº 17. 2012 Full text (in our servers)
  8. Coppa GV, Gabrielli O, Zampini L, Galeazzi T, Maccari F, Buzzega D, Galeotti F, Bertino E, Volpi N. Glycosaminoglycan content in term and preterm milk during the first month of lactation. Neonatology. 2012 Abstract
  9. Coppa GV, Gabrielli O, Buzzega D, Zampini L, Galeazzi T, Maccari F, Bertino E, Volpi N. Composition and structure elucidation of human milk glycosaminoglycans. Glycobiology. 2011 Abstract
  10. Mannello F, Maccari F, Santinelli A, Volpi N. Chondroitin sulfate structure is modified in human milk produced by breast affected by invasive carcinoma. Breast. 2011 Abstract
  11. Viveros-Rogel M, Soto-Ramirez L, Chaturvedi P, Newburg DS, Ruiz-Palacios GM. Inhibition of HIV-1 infection in vitro by human milk sulfated glycolipids and glycosaminoglycans. Adv Exp Med Biol. 2004 Abstract
  12. Newburg DS. Human milk glycoconjugates that inhibit pathogens. Curr Med Chem. 1999 Abstract
  13. Newburg DS. Oligosaccharides and glycoconjugates in human milk: their role in host defense. J Mammary Gland Biol Neoplasia. 1996 Abstract
  14. Newburg DS, Linhardt RJ, Ampofo SA, Yolken RH. Human milk glycosaminoglycans inhibit HIV glycoprotein gp120 binding to its host cell CD4 receptor. J Nutr. 1995 Abstract
  15. Sekine H, Ohno T, Kufe DW. Purification and characterization of a high molecular weight glycoprotein detectable in human milk and breast carcinomas. J Immunol. 1985 Abstract

Total visits

645

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write to us at elactancia.org@gmail.com

e-lactancia is a resource recommended by Academy of Breastfeeding Medicine from United States of America

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM